Category: Healthcare

  • Pupillometer Market

    by

    The Pupillometer Market is poised for substantial expansion, with an estimated valuation of US$ 486.56 million in 2025, reaching US$ 910.56 million by 2035.

  • Pyomyositis Market

    by

    The pyomyositis market is projected to reach a value pool of US$ 26 billion by 2025 and is expected to grow at a CAGR of 5.8%, reaching US$ 41 billion by 2035.

  • qPCR Instruments Market

    by

    The global qPCR instruments market is set for substantial growth, with an estimated market value of USD 1.4 billion in 2024, projected to reach USD 1.9 billion by 2034. This reflects a compound annual growth rate (CAGR) of 4.5% over the forecast period.

  • Quadriplegia Treatment Market

    by

    The global quadriplegia treatment market is projected to reach US$ 2.5 billion by 2025, expanding at a CAGR of 5.7% over the forecast period.

  • Quantitative Pathology Imaging Market

    by

    The global quantitative pathology imaging market is projected to reach US$ 3.77 billion by 2025 and is expected to grow at a CAGR of 12.9%, reaching US$ 10.5 billion by 2035.

  • Radial Compression Devices Market

    by

    The global radial compression devices market is projected to reach US$ 256.5 million by 2025, expanding at a CAGR of 9.9% over the forecast period.

  • Radiation Therapy Software Market

    by

    The global radiation therapy software market is projected to reach US$ 455.9 million by 2025, expanding at a CAGR of 9.2% over the forecast period.

  • Radiation-Induced Fibrosis Treatment Market

    by

    The global radiation-induced fibrosis treatment market is projected to reach USD 74.8 million by 2025 and is expected to grow at a CAGR of 7.4%, reaching USD 138.1 million by 2035.

  • Radio Frequency Beauty Equipment Market

    by

    The global radio frequency (RF) beauty equipment market is expected to reach US$ 1,948.8 million by 2035, growing at a CAGR of 18.8% from US$ 378.7 million in 2025.

  • Radioimmunoassay (RIA) Market

    by

    The global radioimmunoassay market is projected to achieve a valuation of US$ 452.0 million in 2024, expanding at a robust CAGR of 5.4%, and is expected to reach approximately US$ 692.8 million by 2034.